Childs E, Swan H, Evans L, Parchman ML, Ike B, Baldwin LM, Bacon O, Perfetto D, Hogan E, Shoemaker-Hunt SJ. A toolkit to implement opioid quality improvement efforts in primary care: Findings from a mixed-methods study. J Opioid Manag. 2025 Jan-Feb;21(1):29-40. doi: 10.5055/jom.0894. PubMed

Clark CR, Lykken JM, Chen PM, Haas JS, Feldman S, Ahn C, Gu CA, Kobrin S, Silver MI, Atlas SJ, Chubak J, Tiro JA. Barriers to the equitable implementation of risk-based cervical cancer management guidelines. J Gen Intern Med. 2025 May 30. doi: 10.1007/s11606-025-09611-6. Online ahead of print. PubMed

Clark NM, Maine RG, Hantouli MN, Cooper E, Porter A, Sitlani CM, Smith NL, Davidson GH. Evaluation of interfacility transfer patterns among patients with emergency general surgery conditions.  Surgery. 2025 Aug;184:109448. doi: 10.1016/j.surg.2025.109448. Epub 2025 Jun 4. PubMed

Clennin M, Schootman M, Tucher EL, Reifler LM, Vupputuri S, Brown MC, Daugherty SL. Social risk and acute healthcare utilization among insured adults. JAMA Netw Open. 2025 Apr 1;8(4):e254253. doi: 10.1001/jamanetworkopen.2025.4253. PubMed

Cohen P, Lambson BE, Mkhize NN, Moodley C, Yssel AEJ, Moyo-Gwete T, York T, Gwashu-Nyangiwe A, Ndabambi N, Thebus R, Juraska M, deCamp AC, Williamson BD, Magaret CA, Gilbert PB, Westfall D, Deng W, Mullins JI, Morris L, Williamson C, Moore PL. Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: Implications for cross-resistance. J Virol. 2025;99(2):e0173024. doi: 10.1128/jvi.01730-24. Epub 2025 Jan 16.  PubMed

Cook AJ, Heagerty PJ. Direct effect modeling methods to estimate heterogeneity of treatment effects.  JAMA Netw Open. 2025 Jul 1;8(7):e2522397. doi: 10.1001/jamanetworkopen.2025.22397. PubMed

Cruz M, Shortreed SM, Simon GE, Coley Y. Evaluating clinical implementation of risk prediction based interventions using difference-in-differences.  Health Serv Res. 2025 Jul 21:e70015. doi: 10.1111/1475-6773.70015 [Epub ahead of print] PubMed

Curtis LH, Morain S, O'Rourke PP, Staman K, Jarvik JG, Cheville A, Dailey DL, Sluka KA, Heagerty P, Melnick ER, Chakraborty H, Tulsky JA, Volandes A, Simon GE. Monitoring in pragmatic trials lessons from the NIH pragmatic trials collaboratory.  Contemp Clin Trials. 2025 May;152:107866. doi: 10.1016/j.cct.2025.107866. Epub 2025 Feb 25. PubMed

Davidson O, Lee ML, Kam JP, Brush M, Rajesh A, Blazes M, Arterburn DE, Duerr E, Gibbons LE, Crane PK, Lee CS. Associations between dementia and exposure to topical glaucoma medications.  J Alzheimers Dis. 2025;103(3):679-686. doi: 10.1177/13872877241305745. Epub 2025 Jan 21.  PubMed

DeSilva MB, Haapala J, Vazquez-Benitez G, Daley MF, Lewin B, Klein NP, Liles EG, Jackson LA, Williams JTB, Donahue JG, Katherine Yih W, Kharbanda EO. COVID-19 and completion of select routine childhood vaccinations. Pediatrics. 2025 Apr 1;155(4):e2024068244. doi: 10.1542/peds.2024-068244. PubMed

Dorsey S, AlRasheed R, Kerns SE, Meza RD, Triplett N, Deblinger E, Jungbluth N, Berliner L, Naithani L, Pullmann MD. A randomized controlled trial testing supervision strategies in community mental health. Implement Res Pract. 2025 May 23;6:26334895251330523. doi: 10.1177/26334895251330523. eCollection 2025 Jan-Dec. PubMed

El Sahly HM, Anderson EJ, Jackson LA, Neuzil KM, Atmar RL, Bernstein DI, Chen WH, Creech CB, Frey SE, Goepfert P, Meier J, Phadke V, Rouphael N, Rupp R, Stapleton JT, Spearman P, Walter EB, Winokur PL, Yildirim I, Williams TL, Oshinsky J, Coughlan L, Nijhuis H, Pasetti MF, Krammer F, Stadlbauer D, Nachbagauer R, Tsong R, Wegel A, Roberts PC. Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.  Vaccine. 2025;47:126689. doi: 10.1016/j.vaccine.2024.126689. Epub 2025 Jan 4.  PubMed

Ellis RL, Hallgren KA, Williams EC, Glass JE, Rhew IC, Oliver M, Bradley KA. Variations in documentation of alcohol use disorder (AUD) diagnoses across race, ethnicity, and sex in a health system that assesses AUD symptoms as part of routine primary care. J Subst Use Addict Treat. 2025 Feb 24:209654. doi: 10.1016/j.josat.2025.209654. Online ahead of print. PubMed

Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB; Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. Neutralizing antibody immune correlates for a recombinant protein vaccine in the COVAIL trial. Clin Infect Dis. 2025 Feb 5;80(1):223-227. doi: 10.1093/cid/ciae465. PubMed

Franklin IR, Gambatese R, Duggan MC, Green BB, Nocon RS, Coronado GD, Hahn EE, Honda SA, Koplan K, Levin TR, Steiner CA, Ngo-Metzger Q. Colorectal cancer screening and social needs. J Am Board Fam Med. 2025;37(5):868-887. doi: 10.3122/jabfm.2023.230497R1.  PubMed

Frey SE, Brady R, Jackson L, Goepfert P, El Sahly HM, Atmar RL, Rupp R, Creech CB, Abate G, Paulsen G, Weiss J, Wegel A, Roberts PC. Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®. Vaccine. 2025;47:126702. doi: 10.1016/j.vaccine.2024.126702. Epub 2025 Jan 10. PubMed

Frutos AM, Cleary S, Reeves EL, Ahmad HM, Price AM, Self WH, Zhu Y, Safdar B, Peltan ID, Gibbs KW, Exline MC, Lauring AS, Ball SW, DeSilva M, Tartof SY, Dascomb K, Irving SA, Klein NP, Dixon BE, Ong TC, Vaughn IA, House SL, Faryar KA, Nowalk MP, Gaglani M, Wernli KJ, Murugan V, Williams OL, Selvarangan R, Weinberg GA, Staat MA, Halasa NB, Sahni LC, Michaels MG, Englund JA, Kirby MK, Surie D, Dawood FS, Clopper BR, Moline HL, Link-Gelles R, Payne AB, Harker E, Wielgosz K, Weber ZA, Yang DH, Lewis NM, DeCuir J, Olson SM, Chung JR, Flannery B, Grohskopf LA, Reed C, Garg S, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators. Interim estimates of 2024-2025 seasonal influenza vaccine effectiveness - four vaccine effectiveness networks, United States, October 2024 - February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27;74(6):83-90. doi: 10.15585/mmwr.mm7406a2. PubMed

Garcia S, Mahmud A, Dumke K, Erkenbeck A, Chao C, Mun S, Brown M. Understanding, assessing, and improving social health resource referrals in healthcare organizations. Health Serv Res. 2025 Feb 26:e14466. doi: 10.1111/1475-6773.14466. Online ahead of print. PubMed

Garduno AC, Patel SR, Gallo LC, Natarajan L, Parada H, McEvoy LK, Smarr B, LaCroix AZ. Sleep, rest-activity rhythms, and the Charlson Comorbidity Index in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and Sueño. Chronobiol Int. 2025 Aug 22:1-15. doi: 10.1080/07420528.2025.2547026 [Epub ahead of print] PubMed

Gould MK, de Bie E, Qi L, Creekmur B, Mazzone PJ, Mularski RA, Ritzwoller DP, Slatore CG, Vachani A, Walter EC, Wiener RS, Dyer DS, McEvoy CE, Kelly K, Smith-Bindman R, Miglioretti DL; Watch the Spot Investigators. Baseline characteristics of participants and pulmonary nodules in the Watch the Spot Trial: A pragmatic trial of less versus more intensive strategies for active surveillance of patients with small pulmonary nodules. Clin Lung Cancer. 2025 May 24:S1525-7304(25)00122-6. doi: 10.1016/j.cllc.2025.05.011. Online ahead of print. PubMed